We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
179 hedge funds and large institutions have $1.95B invested in Axsome Therapeutics in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 66 increasing their positions, 59 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 17
14% more capital invested
Capital invested by funds: $1.71B → $1.95B (+$245M)
12% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 59
3% more funds holding
Funds holding: 174 → 179 (+5)
0.29% less ownership
Funds ownership: 64.51% → 64.22% (-0.29%)
10% less call options, than puts
Call options by funds: $49.9M | Put options by funds: $55.3M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
179
Holders Change
+5
Holders Change %
+2.87%
% of All Funds
3.17%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
22
Increased
66
Reduced
59
Closed
17
Calls
$49.9M
Puts
$55.3M
Net Calls
-$5.34M
Net Calls Change
+$16.4M
Top Buyers
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$28.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.7M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.3M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$13.5M |
| 5 |
Goldman Sachs
New York
|
-$11.4M |
